Trade Novavax Inc - NVAX CFD
What is Novavax Inc (NVAX)?
Novavax Inc is a biotechnology company specializing in the development of vaccines to prevent infectious diseases. The company utilizes proprietary recombinant nanoparticle technology combined with adjuvants to enhance immune responses. Its vaccine candidates target a range of viral pathogens, aiming to provide effective immunization solutions. Novavax's research and development efforts focus on creating vaccines that are scalable and accessible for global health needs. The company collaborates with government agencies, research institutions, and industry partners to advance its vaccine pipeline. Novavax operates within the biopharmaceutical sector, contributing to public health initiatives through innovative vaccine technologies. Its work encompasses preclinical and clinical development stages, with an emphasis on safety and efficacy.
Novavax Inc Stock Price Today: Live Overview
The price today is shaped by intraday market action, with Novavax Inc trading at $7.83. The price has moved between $7.52 and $8.01, reflecting a daily change of -4.1199%.
FAQ: Novavax Inc (NVAX)
What is the current price of NVAX stock?
The last traded price is $7.83.
Does NVAX pay dividends?
Novavax Inc does not pay dividends.
Does NVAX have a formal corporate presence or regional headquarters in the UAE?
Novavax Inc does not have an official presence in the UAE and operates through partners only.
What is NVAX best known for?
Novavax Inc is most famous for its development of vaccines, including those for COVID-19.
What assets are typically shown together with NVAX?
Commonly shown alongside NVAX: American Well Corporation, Far East HTrust, Tredegar Corp
Latest shares articles



